Daisy Roser
Commissioner for Food and Drug Administration (FDA) Marty Makary said in an interview with Dasha Burns Politico that the FDA “looks at the data” surrounding abortion drugs, Mifepriston, including fear “that pregnant women suffer from forced to take a pill” except for prescribing a doctor. “
Commissioner he said It consists in that the FDA conducts a “continuous review of security data on Mifepriston”, which noticed “is a requirement of previous administrations” in a video clip from an interview published on Friday. Makary also said that the FDA analyzes the circumstances in which women receiving this abortion pill affect “abuse, imbalance of power from a man in a relationship.”
In an interview, which is to be fully issued in the Sunday episode of “The Conversation” Politico, Makary said that it was data that shows every “new drug interaction with Mifepristone”, FDA “would have to take action”.
“You always have to be open,” Makary added. “You must listen to different opinions and, you know, make decisions based on what you consider to be appropriate.”
He said that the FDA must “listen to what is happening in the field and ask, you know what we can do to do our role?”
However, the Commissioner also said that “there are no pre -accepted plans to introduce any changes in Mifepristone’s policy,” especially related to “Terade and mail”.
Burns, at the beginning of the video clip, clearly admitted that the Republican Senator Missouri Josh Hawley exerts pressure on the FDA to “limit access to Mifepristone through teeth and mail.”
“I don’t feel that I am under pressure from nobody,” said Makary Burns after she mentioned the name of the senator. “Now people have opinions.”
Hawley introduced Legislation in May “to restore security regulations” against Mifepriston. Hawley sent letter To Makara in April, emphasizing studies showing many stern negative side effects of an abortion drug.
The senator doubled on Tuesday, z letter to the Secretary for Health and Social Welfare (HHS) Robert F. Kennedy Jr., calling to the secretary to “reverse changes in the assessment of the risk and strategy of relieving Mifepristone (REMS) made during the Democratic Presidential Administration, which weakened women’s protection.”
Daily Caller News Foundation tested Shipping restrictions on mifepriston abortion pills by ordering a drug from various companies. The organization was not obliged to talk to the doctor to prove the rights at every opportunity.
Recent lawsuit Against the planned parenting from the Republican Prosecutor General Andrew Bailey, he claims that the company tried to raise revenues, submitting “brazenly false” claims regarding the safety of the abortion pill, while the study from the Center for Ethics and Public Policy (EPPC) published in April shown that 1 in 10 women experience a “serious adverse event” after taking an abortion pill.
FDA rejected and constrained a number of experimental drugs in recent days, limit Rejected slimming drugs in May and even moving to inflammation distance with Sarepta over experimental gene treatment. Makary condemned on Wednesday danger fluoride in drinking water, and FDA He retreated On the recommendations regarding the annual Covid shot in May, which suggests re -emphasis on drug safety in FDA.
– – –
Daisy Roser is a reporter at the Daily Caller News Foundation.
Photo “Mifepristone” by Robin Marta. CC at 2.0.
